As Vice-Chair, Dr. Susan E Cohn will work closely with Dr. Adriana Weinberg, Chair of A5392, and Dr. Kim Scarsi, co-Vice Chair to finalizing the A5392 protocol and oversee the overall conduct of this clinical trial. She will work closely with the entire study team to respond to the sites questions about the study, including procedures and/or patient eligibility concerns, and help to ensure that the protocol is enrolled and conducted in a timely fashion. She will review safety reports with the A5392 Core team and ensure the Team responds to site or ACTG leadership inquiries promptly, and participate on regular and ad hoc A5392 Team calls. After study completion, Dr. Cohn will work with the A5392 Team to review the final data report and work with the A5392 Writing team to write and finalize manuscripts describing study outcomes and safety.
|Effective start/end date||12/1/20 → 11/30/27|
- University of California, Los Angeles (1560 G YB725 Amnd 2 // 5UM1AI068636-16)
- National Institute of Allergy and Infectious Diseases (1560 G YB725 Amnd 2 // 5UM1AI068636-16)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.